000 | 01977 a2200577 4500 | ||
---|---|---|---|
005 | 20250514074306.0 | ||
264 | 0 | _c20031014 | |
008 | 200310s 0 0 eng d | ||
022 | _a0306-4522 | ||
024 | 7 |
_a10.1016/s0306-4522(03)00268-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMilhaud, D | |
245 | 0 | 0 |
_aNeuroprotective activity of antazoline against neuronal damage induced by limbic status epilepticus. _h[electronic resource] |
260 |
_bNeuroscience _c2003 |
||
300 |
_a475-84 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aAntazoline _xtherapeutic use |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aElectric Conductivity |
650 | 0 | 4 |
_aElectroencephalography _xinstrumentation |
650 | 0 | 4 | _aExcitatory Amino Acid Agonists |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHippocampus _xcytology |
650 | 0 | 4 |
_aHistamine H1 Antagonists _xtherapeutic use |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscarinic Agonists _xadministration & dosage |
650 | 0 | 4 | _aN-Methylaspartate |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 |
_aPilocarpine _xadministration & dosage |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aStatus Epilepticus _xchemically induced |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTrauma, Nervous System _xetiology |
700 | 1 | _aRondouin, G | |
700 | 1 | _aLerner-Natoli, M | |
700 | 1 | _aBockaert, J | |
700 | 1 | _aLafon-Cazal, M | |
773 | 0 |
_tNeuroscience _gvol. 120 _gno. 2 _gp. 475-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(03)00268-9 _zAvailable from publisher's website |
999 |
_c12667210 _d12667210 |